Literature DB >> 12943800

Native and recombinant interleukin-2, two functionally distinct molecules.

Maria C Denis1, Brigitte T Huber.   

Abstract

Recombinant IL-2 (rIL-2) produced in prokaryotes, is widely used in lieu of native IL-2, which is secreted by T cells, to assess the functional profile of this cytokine. We provide evidence that a naturally occurring species of post-translationally modified IL-2 (moIL-2) exhibits enhanced bioactivity compared to rIL-2, as tested at the biochemical and functional level. We show that moIL-2 has high binding affinity for the IL-2 receptor (IL-2R), induces the immediate expression of the IL-2R alpha chain and rapidly activates downstream signaling molecules. Finally, in contrast to rIL-2, moIL-2 can promote the antigen-independent proliferation of resting lymphocytes. Collectively, our data demonstrate that native moIL-2 is functionally distinct from rIL-2, suggesting the existence of diverse IL-2 variants which may be critical for the shaping of the immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943800     DOI: 10.1016/s0161-5890(03)00102-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Ripe Tomato Saponin Esculeoside A and Sapogenol Esculeogenin A Suppress CD4+ T Lymphocyte Activation by Modulation of Th2/Th1/Treg Differentiation.

Authors:  Jian-Rong Zhou; Rie Yamada; Erina Huruiti; Nozomi Kitahara; Honami Nakamura; Jun Fang; Toshihiro Nohara; Kazumi Yokomizo
Journal:  Nutrients       Date:  2022-05-11       Impact factor: 6.706

2.  Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors.

Authors:  Amanda M Nash; Maria I Jarvis; Samira Aghlara-Fotovat; Sudip Mukherjee; Andrea Hernandez; Andrew D Hecht; Peter D Rios; Sofia Ghani; Ira Joshi; Douglas Isa; Yufei Cui; Shirin Nouraein; Jared Z Lee; Chunyu Xu; David Y Zhang; Rahul A Sheth; Weiyi Peng; Jose Oberholzer; Oleg A Igoshin; Amir A Jazaeri; Omid Veiseh
Journal:  Sci Adv       Date:  2022-03-02       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.